Policy & Advocacy

The debate over the proposed Uniform Guidance revisions—and particularly their potential effects on peer review, negotiated indirect cost rates, and research grant administration—emerged as one of the central issues of the hearing

A renowned evolutionary biologist and science communicator, Shubin's vision for NASEM supports basic and applied fields, emphasizes its advisory role to decision-makers, and looks to increase public outreach.

NIH argues that redistributing funding currently concentrated among a small number of highly-funded PIs would broaden the geographic and institutional distribution of funding, expand opportunities for early-stage and mid-career researchers, and improve mentoring, rigor, and reproducibility.

Use FASEB's three-step tool to help you generate a letter defending research in response to the OMB Proposed Rule. Comments close July 13, 2026 at 11:59 PM EST.

The National Institutes of Health is engaging stakeholders in defining specific, measurable indicators and incentives that reflect the collaborative, rigorous, and mission-driven nature of modern biomedical science.

Join others in the GSA community for a working session to draft your comment on the recently proposed Office of Management and Budget “Regulation for Federal Financial Assistance” by the July 13 deadline.

The May 14–15 NIH Council of Councils meeting highlighted several themes shaping NIH priorities, including chronic disease prevention, rigor and reproducibility, implementation-oriented science, and shared research infrastructure.

This free guide explains details of OMB's proposed rule and offers actionable tips for scientists to oppose it. Comments are due to OMB by July 13.

Register for Stand Up for Science's emergency meeting at 4 p.m. EDT to discuss the effects of OMB’s Proposed Federal Financial Assistance Rule and how to take action to defend scientific research.

Former GSA Board member Brandon Ogbunu will moderate this event, which will discuss the status of the U.S. research enterprise, global leadership in science, and implications for economic competitiveness.

This congressionally-mandated, data-rich report (released biannually) summarizes the patterns in US science R&D and workforce development, as well as the impacts of federal STEM funding.